JP2022514704A5 - - Google Patents
Info
- Publication number
- JP2022514704A5 JP2022514704A5 JP2021536212A JP2021536212A JP2022514704A5 JP 2022514704 A5 JP2022514704 A5 JP 2022514704A5 JP 2021536212 A JP2021536212 A JP 2021536212A JP 2021536212 A JP2021536212 A JP 2021536212A JP 2022514704 A5 JP2022514704 A5 JP 2022514704A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- comp
- fusion protein
- glycosylated
- tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024214739A JP2025032259A (ja) | 2018-12-21 | 2024-12-09 | O結合型グリコシル化認識モチーフ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862783971P | 2018-12-21 | 2018-12-21 | |
| US62/783,971 | 2018-12-21 | ||
| PCT/US2019/059893 WO2020131236A1 (en) | 2018-12-21 | 2019-11-05 | O-linked glycosylation recognition motifs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024214739A Division JP2025032259A (ja) | 2018-12-21 | 2024-12-09 | O結合型グリコシル化認識モチーフ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514704A JP2022514704A (ja) | 2022-02-14 |
| JP2022514704A5 true JP2022514704A5 (cg-RX-API-DMAC7.html) | 2022-11-11 |
| JP7699543B2 JP7699543B2 (ja) | 2025-06-27 |
Family
ID=71101542
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536212A Active JP7699543B2 (ja) | 2018-12-21 | 2019-11-05 | O結合型グリコシル化認識モチーフ |
| JP2024214739A Withdrawn JP2025032259A (ja) | 2018-12-21 | 2024-12-09 | O結合型グリコシル化認識モチーフ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024214739A Withdrawn JP2025032259A (ja) | 2018-12-21 | 2024-12-09 | O結合型グリコシル化認識モチーフ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12350342B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3897685B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7699543B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019404924B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3124312A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3055827T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020131236A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265391B2 (en) | 2015-02-26 | 2019-04-23 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| ES3051337T3 (en) | 2018-06-16 | 2025-12-26 | Vaxnewmo Llc | Glycosylated comp pilin variants, methods of making and uses thereof |
| US12350342B2 (en) | 2018-12-21 | 2025-07-08 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
| EP4271417A4 (en) * | 2020-12-31 | 2024-11-27 | Vaxnewmo Llc | GLYCOSYLATED KLEBSIELLA PNEUMONIAE O-ANTIGEN AND METHODS OF PREPARATION AND USES THEREOF |
| JP2024517754A (ja) * | 2021-04-28 | 2024-04-23 | ヴァックスニューモ エルエルシー | O-結合型グリコシル化に十分な最小シークオン |
| CN115120712B (zh) * | 2022-06-30 | 2025-11-18 | 中国人民解放军军事科学院军事医学研究院 | 肺炎链球菌糖蛋白生物结合疫苗及其制备方法和应用 |
| AU2023356184A1 (en) * | 2022-10-07 | 2025-04-17 | Vaxnewmo Llc | Moraxellaceae o -linking oligosaccharyltransferases, glycosylation fragments, and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US9238830B2 (en) | 2006-12-13 | 2016-01-19 | The Governors Of The University Of Alberta | Methods and systems for O-glycosylating proteins |
| US20130196410A1 (en) * | 2010-03-05 | 2013-08-01 | Alnylam Pharmaceuticals, Inc | Compositions and methods for modifying the glycosylation pattern of a polypeptide |
| EP2742355B1 (en) | 2011-08-12 | 2018-12-19 | The Governors of the University of Alberta | Method of diagnosing bacterial infections using bacterial glycoproteins |
| IN2014CN04076A (cg-RX-API-DMAC7.html) | 2011-11-04 | 2015-10-23 | Univ Cornell | |
| KR20150068998A (ko) | 2012-10-12 | 2015-06-22 | 글리코박신 아게 | 숙주 세포 변형 방법 |
| EP2917351B1 (en) * | 2012-11-07 | 2018-12-19 | GlaxoSmithKline Biologicals S.A. | Production of recombinant vaccine in e. coli by enzymatic conjugation |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| JP6356229B2 (ja) | 2013-06-04 | 2018-07-11 | アイコン ジェネティクス ゲーエムベーハー | 植物産生糖タンパク質及び組換え糖タンパク質のn−グリコシル化部位占有率を調節する方法 |
| US9988426B2 (en) | 2014-09-18 | 2018-06-05 | University Of Maryland, Baltimore | Broad spectrum conjugate vaccine to prevent Klebsiella pneumoniae and Pseudomonas aeruginosa infections |
| SI3240895T1 (sl) * | 2014-12-30 | 2022-04-29 | Glaxosmithkline Biologicals S.A. | Sestavki in postopki za glikozilacijo proteinov |
| US10265391B2 (en) * | 2015-02-26 | 2019-04-23 | Vaxnewmo Llc | Acinetobacter O-oligosaccharyltransferases and uses thereof |
| US11279943B2 (en) * | 2017-01-17 | 2022-03-22 | Bioapplications Inc. | Recombinant vector for expressing target protein in plant cell |
| EP3492481A1 (en) | 2017-11-30 | 2019-06-05 | Vaxxilon AG | Vaccine against klebsiella pneumoniae |
| ES3051337T3 (en) * | 2018-06-16 | 2025-12-26 | Vaxnewmo Llc | Glycosylated comp pilin variants, methods of making and uses thereof |
| JP7551618B2 (ja) | 2018-12-12 | 2024-09-17 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | O-結合型グリコシル化のための修飾キャリアタンパク質 |
| US12350342B2 (en) | 2018-12-21 | 2025-07-08 | Vaxnewmo Llc | O-linked glycosylation recognition motifs |
-
2019
- 2019-11-05 US US17/416,106 patent/US12350342B2/en active Active
- 2019-11-05 AU AU2019404924A patent/AU2019404924B2/en active Active
- 2019-11-05 CA CA3124312A patent/CA3124312A1/en active Pending
- 2019-11-05 WO PCT/US2019/059893 patent/WO2020131236A1/en not_active Ceased
- 2019-11-05 EP EP19898969.1A patent/EP3897685B1/en active Active
- 2019-11-05 ES ES19898969T patent/ES3055827T3/es active Active
- 2019-11-05 JP JP2021536212A patent/JP7699543B2/ja active Active
-
2024
- 2024-12-09 JP JP2024214739A patent/JP2025032259A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021528059A5 (cg-RX-API-DMAC7.html) | ||
| ES2657588T3 (es) | Vacunas de bioconjugados de bacterias grampositivas capsulares | |
| US12173033B2 (en) | Immunogenic fusion protein | |
| RU2005119640A (ru) | Множественные варианты менингококкового белка nmbi1870 | |
| JP2023531242A5 (cg-RX-API-DMAC7.html) | ||
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| CN116209753A (zh) | 肺炎克雷伯氏菌o-抗原疫苗 | |
| JP2002541808A (ja) | ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア | |
| EP2292644A2 (en) | Small Streptococcus pyogenes antigens and their use | |
| RU2002117308A (ru) | 85 кДа АНТИГЕН NEISSERIA | |
| US20190248841A1 (en) | Immunogenic Composition | |
| AU2019404924B2 (en) | O-linked glycosylation recognition motifs | |
| JP5744842B2 (ja) | 髄膜炎菌と肺炎球菌との結合型ワクチン及びそれを使用する方法 | |
| CN111801343A (zh) | 免疫原性组合物 | |
| TW202304504A (zh) | 大腸桿菌o18生物軛合物之生產 | |
| JP5661744B2 (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| CN111741765A (zh) | 免疫原性组合物 | |
| JP2024517754A5 (cg-RX-API-DMAC7.html) | ||
| AU733845B2 (en) | Immunogenic complex, use, method of preparation thereof and vaccine containing same | |
| CN107847578A (zh) | 免疫原性组合物 | |
| JP6230991B2 (ja) | エンテロコッカス・フェシウムクローナルコンプレックス17に由来するラムノ多糖及びその使用 | |
| EP0595188B1 (en) | Process for producing vaccine for a bacterial toxin belonging to the RTX toxin family | |
| JP2025514731A5 (cg-RX-API-DMAC7.html) | ||
| JP2021526547A5 (cg-RX-API-DMAC7.html) | ||
| JP2020537488A5 (cg-RX-API-DMAC7.html) |